INTRODUCTION

Investigation of common variable immunodeficiency
Common variable immunodeficiency (CVI) 3 is a het-(CVI) is hampered by lack of a suitable in vitro models. erogeneous syndrome characterized by hypogamWe have developed EBV-transformed B lymphoblas-maglobulinia and clinically dominated by recurrent cule that can induce apoptosis, was increased on the lymphopenia. Isolated CVI B cells generally proliferate CVI B cell lines while CD38, a novel signaling molecule normally in vitro while failing to differentiate into imwhose stimulation may prevent apoptosis, showed re-munoglobulin-secreting cells. Such studies have been duced expression. The B cell lines from the CVI pa-taken to indicate that isolated CVI patient B cells mantients exhibit increased apoptosis in vitro spontane-ifest a differentiation defect (3, 4) . Additional evidence ously, in response to anti-CD95 mAb and to X-irradia-has suggested that the B cells in the patients are immation. These phenotypic and functional changes are ture and do not represent true mature memory B cells. similar to findings on freshly derived B cells from the Such data include altered cell surface molecule dispatients. EBV-derived B cell lines from patients with plays, defective class switching, a restricted and immahyper-IgM immunodeficiency and X-linked agamma-ture use of VH genes, and increased spontaneous globulinemia did not demonstrate increased CD95 ex-apoptosis (5-8). Studies have also indicated T cells' pression or enhanced apoptosis. Thus the EBV-derived abnormalities, such as defective signal transduction, B cell lines from our selected CVI patients manifest an abnormal phenotype of circulating cells, and remany characteristics of the patients' fresh cells and duced proliferation and cytokine production in remay provide critical reagents for the further elucida-sponse to stimulation to mitogens and antigen (9) (10) (11) . tion of the nature of the B cell dysfunction in the se-Indeed the phenotype of CVI subjects, when investilected subset of CVI patients. ᭧ 1995 Academic Press, Inc. gated in depth, is generally a complex defect involving B cells, T cells, and even antigen-presenting cells. Thus it remains very difficult to determine where the primary defect(s) lies as abnormalities in differing im-common precursor, primary defects acquired in distinct characterized clinically and immunologically in previous reports and identified by their UCLA-CIA identificell populations, or a single lineage defect with secondary abnormalities resulting from a disturbance in the cation numbers (CVI nos. 109, 111, 153, 128, 144, 175) employed in earlier publications (4, 6, 7, 15) . All paextensive interactions required between various immune cell populations in order to achieve normal T and tients had low levels of serum Ig and low to normal circulating percentages of B cells. The B cells from B cell development.
This progress in understanding the immunopathogen-these patients exhibited altered cell surface molecule displays, defects in Ig production in response to various esis of CVI in patients has been achieved almost exclusively using small numbers of freshly obtained cells. stimuli, and enhanced apoptosis, as reported. Normal control subjects were laboratory personnel from the These cells necessarily represent a momentary ''snap shot'' of a mixed population of the specific cells under UCLA Center for the Health Sciences. Informed consent was obtained from all patients and normal coninvestigation. This reliance on fresh cells has also prevented the repeat evaluation of the identical cells and trols and the study was approved by the UCLA Institutional Review Board. specific corroborative studies by various investigators. Furthermore, in depth studies of the fundamental molecProduction of EBV-Transformed B Lymphoblastoid ular underlying mechanisms of these cellular defects are
Cell Lines hampered by the lack of a suitable animal model or a reproducible long-term human cell CVI model.
Peripheal blood mononuclear cells were isolated by We have undertaken to derive permanent relatively Ficoll-Hypaque density centrifugation from freshly obstable cells that represent the B cells present in a sub-tained blood of CVI patients and normal controls. The set of patients with CVI. Previously we have derived freshly isolated mononuclear cells (1 1 10 6 ) cells were B cell hybridomas from CVI patients (12) . These cloned placed in 24-well plates along with 1 ml of supernatant lines have the disadvantage of having two genomes. from the productively infected marmoset cell line B95-We and others have employed IL-4 plus anti-CD40 to 8 and incubated in a humidified atmosphere of 5% CO 2 drive differentiation by CVI V cells but this system has at 37ЊC. After 1 week the supernatant was replaced been generally disappointing in its utility for deriving with 1 ml of fresh medium which was replaced twice a long-term cell lines in general. EBV can be used with week thereafter. After 3-4 weeks, the cells were exalmost uniform success in establishing cell lines from panded into flasks. The cells were maintained at benormals and patients with a variety of disorders, as it tween 10 5 and 10 6 /ml in RPMI 1640 medium supplesimply relies on the presence of B cells expressing mented with 10% heat-inactivated FCS, 1% penicillin/ CD21. B cell lines from patients with CVI have been streptomycin, and glutamine for a minimum of 3 established in this fashion and used in the analysis of months. EBV-transformed sIgM-positive B cell lines their Ig genes (13, 14) . On the other hand, as EBV-from two patients with hyper-IgM immunodeficiency transformed CVI B cells generally have made IgM in (HIgM) were the kind gift of Dr. Ochs (University of a manner similar to normal EBV lines, these cell lines Washington Medical School, Seattle, WA). An EBVhave not been felt to be useful in studying the immuno-transformed sIgM-positive B cell line from patients pathophysiology of the patients' B cells.
with X-linked agammaglobulinaemia (XLA) and Having carefully defined a subset of patients with CVI proven BTK deficiency was the kind gift of Dr. David for surface phenotype, Ig production, and susceptibility Rawlings (UCLA School of Medicine, Los Angeles, CA.). to apoptosis, we established a large number of EBV im-HIgM is characterized by normal or elevated levels of mortalized B cell lines from these patients and careful IgM and markedly decreased levels of IgG, IgA, and analyzed them for lines expressing phenotypic and func-IgE. XLA patients have an arrest of early B lymphoid tional characteristics of the immature B cells found circu-development, profoundly decreased numbers of circulating in the patients from whom they were derived. lating B cells, and very little Ig of any isotype. Some of these lines appear to have characteristics of CVI B cells, expressing increased levels of sIgM and CD95 Flow Cytometric Analysis and decreased levels of sIgD, sIgG, and CD38 expression. These lines are defective in the production of IgG and Flow cytometric analysis of cell surface molecules IgA and more readily undergo spontaneous or induced was performed as described previously (4) . The followprogrammed cell death compared with EBV-derived nor-ing monoclonal antibodies directly conjugated with mal B cell lines. These CVI-like B cells should provide FITC or PE were employed: anti-human m, anti-human an important tool in the investigation of CVI.
g, anti-human d, CD19, CD20, CD23, CD25, and CD38 (Becton-Dickinson). For indirect staining of CD95, MATERIAL AND METHODS cells were first labeled with mAb DX2 (anti-CD95, Subjects kindly provided by Dr. Louis Lanier, DNAX Research Institute) followed by PE-conjugated sheep anti-mouse Six patients with CVI were included in this study. These patients were selected from a subset of patients IgG (Southern Biotechnology Associates, Inc., Bir-mingham, AL). For cytoplasmic staining of Bcl-2 and RESULTS myc, 10 5 cells were resuspended in 100 ml PBS/BSA (phosphate-buffered saline plus 2% bovine serum albu-B Lymphoblastoid Cell Lines from the CVI Patients min plus 1% azide) and 2 ml of PermeaFix was added,
Show an Immature Phenotype with Features mixed, and incubated at room temperature for 40 min.
Similar to That Seen in Vivo The cells were then centrifuged, the supernatant was removed, and the cells were resuspended in 100 ml PBS/ We established over 50 B lymphoblastoid cell lines from the six CVI patients whom we had previously BSA along with 10 ml of FITC-labeled anti-Bcl-2 (Dako Corp., Carpinteria, CA) or anti-myc (Oncogen Science, characterized as having defective B cell differentiation in vitro (4, 6, 7) . We simultaneously established 30 B Cambridge, MA) monoclonal antibody. Following incubation at room temperature for 25 min, the cells were lymphoblastoid cell lines from two healthy controls.
The cells were maintained for a minimum of 3 months washed with PBS/BSA and analyzed on a flow cytometer. The flow cytometric data were measured on in culture before being investigated and the cell lines have now been kept in culture for more than 12 months. FACScan (Becton-Dickinson) and analyzed using the LYSIS II software.
Essentially all of the cells (ú95%) in all of the cell lines were positive for both CD19 and CD20 and completely negative for T cell (CD3) and monocyte (CD14) markIg Production in Vitro ers. The baseline level of expression of CD19, CD20, B lymphoblastoid cells (1 1 10 4 ) were cultured in 0.2 CD23, CD25, CD40, CD62L/Leu-8, and CD79b/B-29 ml of complete medium at 37ЊC for 3 days with or with-was no different between the normal and the patient out experimental manipulation as discussed under re-B cell lines. sults. The concentration of IgM, IgG, and IgA in the We determined whether the CVI B cell lines have culture supernatant was measured by isotype-specific altered expressions of CD95 and CD38, surface moleELISAs as previously reported (16) .
cules that we have found to have altered displays on the fresh B cells from this selected subset of CVI patients (7) and which appear to be involved in apoptosis.
Measurement of Cell Proliferation, Viability, and
The results showed that the CVI B cell lines expressed Apoptosis increased levels of CD95 and reduced levels of CD38 in a fashion analogous to fresh cells, as shown in /ml in 24-well plates under 1. As can be readily seen, while B cell lines from patients and healthy controls all express high levels of various conditions in a humidified atmosphere of 5% CO 2 at 37ЊC. At the indicated time points, cell viability CD95, expression of CD95 on patients' cells was still brighter than that on normal cell lines. Results for was determined by trypan blue exclusion or flow cytometry. Detection of apoptotic cells employed a flow cyto-CD38 displays showed that the CVI subjects' B cell lines expressed decreased CD38 expression compared metric procedure that has recently been reported in detail elsewhere (17) . Washed cells were resuspended to that in normals. A summary of CD95 and CD38 expression on the B cell lines is shown in Table 1 . Four in 500 ml PBS plus 0.1% NaN 3 and then 7 aminoactinomycin D (7AAD) (20 mg/ml) was added 15-20 min be-cell lines from two patients express very low levels of CD38 (5-30%), accounting for the large standard devifore analysis on a FACScan flow. The 7AAD bright smaller cells represent the late apoptotic and dead ation. To determine if these changes seen with the CVI B cells might simply reflect changes due to the immacells, the 7AAD intermediate smaller cells represent apoptotic cells, and the 7AAD dim larger cells repre-ture nature of the B cells present in the patients, EBVderived cell lines from patients with HIgM (2) and XLA sent the live cells. Data acquisition was done using FACScan research software and 10,000 events were (1) were analyzed. The HIgM cells expressed normal levels of CD95 and CD38 (85-93%), while the XLA B collected on each sample.
To determine anti-CD95-induced inhibition of cell cells expressed normal levels of CD95 and decreased levels of CD38 (20%). The CVI lines also displayed deproliferation, 5 1 10 4 B cells in 200 ml were incubated with control antibody (mouse IgG1) or anti-CD95 anti-creased numbers of cells with surface IgG and IgA (see below). body (0.1 mg/ml or 0.5 mg/ml, DX2) in 96-well flat-bottom plates for 24 hr. To crosslink CD95, goat antiVarious stimuli that have been shown to specifically alter CVI B cell function and/or phenotype were asmouse IgG (Jackson Immunoresearch, West Grove, PA) at 1 mg/ml was added to all cultures. The cells were sessed for their ability to enhance CD38 expression.
Retinoic acid (10 06 M), which we have shown to induce pulsed with 1 mCi of [ 3 H]thymidine for 4 hr before harvest, and thymidine incorporation was measured. Re-differentiation of CVI B cells in vivo and CVI B cell hybridomas in vitro, increased CD38 expression on sults were expressed as the mean [ 3 H]thymidine incorporation compared with cells treated with control anti-both normal and CVI B cell lines (Fig. 2) . Enhancement of CD38 expression was greater on the CVI B cell lines body and goat anti-mouse IgG. levels of sIgM (97% cells positive, median fluorescence intensity 1168-1170) and minimal levels of sIgG-positive cells (approximately 10%), while the XLA B cell line was sIgM dim (15% positive with median fluorescence of 242) and sIgG-negative. After 6 months in culture, B cell lines from CVI and normal controls usually expressed a single type of light chain showing that the lines had become clonal (data not shown).
The surface Ig phenotype of the CVI B lymphoblastoid cell lines suggested that the patients' cells had generated less isotype-switched B cells in the cultures. Therefore we evaluated their production of the different Ig classes. Figure 4 shows a representative experiment for Ig production by 6 cell lines from three patients. A summary of the results for the 26 patient cell lines tested is given in Table 2 . All of the cell lines from CVI patients produced IgM although some CVI cell lines (e.g., 4C5) secreted very low levels of IgM (less than 0.5 mg/ml). One normal cell line (M7) of 8 tested failed to produce IgM but this normal cell line was found to be producing IgG and IgA. IgM secretion overall from CVI B cell lines (n Å 26) was not significantly different from that seen with normals (n Å 8) (2.97 { 1.9 mg/ml vs 5.77 { 4.5 mg/ml, respectively). The HIgM and XLA B cell lines produced between 1.8 and 2.8 mg/ secreted IgA (0.632-84.34 ng/ml). The HIgM and XLA B cell lines made no detectable IgG or IgA.
As IL-4 plus anti-CD40 and/or IL-10 have been rethan that observed in the normals. In contrast, IL-4 ported to stimulate fresh CVI B cells to produce in-(100 U/ml), IL-10 (500 U/ml), CD40 (0.1 mg/ml) mAb, creased amounts of Ig, we examined the effect of these and PMA (5 ng/ml) all failed to increase CD38 expres-stimuli on Ig production by the transformed B cells. a Results are expressed as the median fluorescence intensity with the percentage of positive cells shown in parenthesis. B cells were stained directly with FITC-labeled CD38 or indirectly with mAb DX2 (specific for CD95) followed by PE-conjugated goat anti-mouse IgG.
b ND, not determined. c P Å 0.020 for CVI vs normal percentage of CD38-positive cells while there was no difference in the CD38 fluorescence intensity (P ú 0.05). P Å 0.005 for CVI vs normal CD95 median fluorescence intensity.
cells. This decreased number of live cells in the CVI difference in [
3 H]thymidine incorporation between norcultures could be accounted for by the fact that the mal and CVI B cell lines (data not shown). To deterviability in the CVI B cell lines was generally 70-80% mine whether this loss of viable and total cells in the compared to the 80-90% viability seen in the normal CVI B cell lines was associated with increased sponta-B cell lines. To determine if this was caused by an neous apoptosis, we analyzed spontaneous apoptosis intrinsically slower rate of proliferation as judged by by flow cytometry, as shown in Table 3 . CVI B cell lines the rate of DNA synthesis, we measured cellular [ 3 H]-had more dead and apoptotic cells than normals. thymidine incorporation. This was performed in shortCrosslinking of CD95 molecules by anti-CD95 mAb term culture (2-4 hr) so as to negate any effects of has been found to inhibit cell growth via apoptosis, and increased cell loss over the culture period. There is no CD95-mediated inhibition of cell proliferation has been taken as an indicator of induction of apoptosis on EBVtransformed B cell lines (18) (19) (20) . Therefore we used this assay to measure the sensitivity to CD95-induced apoptosis in the EBV-transformed CVI versus normal B cell lines. Cells were treated with anti-CD95 mAb (DX2) at 0.1 or 0.5 mg/ml for 24 hr and cell proliferation was measured by [ 3 H]thymidine incorporation. The CVI B cell lines were clearly more sensitive to the inhibitory effect of anti-CD95 mAb at both concentrations tested (Table 4) . Baseline [ 3 H]thymidine incorporation by normal or CVI B cell lines was equivalent and a control murine antibody and goat anti-mouse IgG showed no effect on [ dress the nature of the ''primary defect'' in vivo in CVI, To extend these observations, we determined if the the fact that we were able to derive B cell lines from CVI B cells were also more susceptible to g irradiation-the patients that appear to be abnormal suggests that induced apoptosis. Five out of seven B lymphoblastoid if the defect is not intrinsic to the B cells, then the lack cell lines from CVI patients showed increased sensitiv-of appropriate stimulation in vivo at least leads to B ity to g irradiation (Fig. 6) . In view of this increased cells that are unable to differentiate normally under a apoptosis of CVI B cell lines, we analyzed the cyto-variety of in vitro conditions, including long-term plasmic expression of bcl-2 and c-myc, two molecules growth following EBV transformation. Earlier less deknown to be involved in apoptosis. This revealed no tailed studies found that CVI B, when cultured with difference between the CVI and normal control B cell EBV, proliferated normally and produced normal to lines in the intracellular expression of these molecules. subnormal amounts of IgM (21, 22) .
In depth studies on the B cells in CVI B subjects DISCUSSION have long been hampered by the difficulties in obtaining sufficient purified B cells for long-term study. CVI is a heterogeneous disorder characterized by defective antibody production. The failure of B cells to Thus, because of limited sample size, many studies 104) were cultured in 0.2 ml of complete medium for 3 days at 37ЊC. The concentration of IgM, IgG, and IgA in the culture supernatants was measured by isotype-specific ELISAs. Supernatant Ig levels of greater than 0.5 ng/ml, the lower limit of detection in the ELISAs, were scored as positive. (12) and less sIgG-bearing reflects the data that CVI patients have normal or increased relative amounts of sIgM-positive compared to that of sIgG-positive B cells in the peripheral lymphocyte pool; e.g., Strober et al. (27) found that CVI B cell populations contained an increased percentage of sIgM-bearing cells associated with a reduced percentage of sIgG-bearing and sIgAbearing cells. Similarly, we found that the CVI-derived B cells also demonstrated altered displays of other surface markers (e.g., CD95 and CD38, as discussed below), which we have also observed on fresh cells from these patients. Not all of the phenotypic markers of fresh CVI B cells were observed on the EBV lines; e.g., CD20 and CD62L were normal. Functional study also indicated that although the CVI-derived B cell lines produced normal amounts of IgM, they were almost completely devoid of IgG and IgA production while normal cell lines produced large amounts of IgM, IgG, and detectable levels of IgA. This functional abnormality is similar to results with in vitro Ig production by CVI B cells in which Ig production showing a hierarchy of IgM ӷ IgG ӷ IgA is ob- of Ig switching appears to be represented in the immature Ig phenotype and abnormal Ig production of the CVI B cell lines we derived.
We have found that fresh B cells from CVI patients transfected fibroblast cell line) can drive B cell growth and differentiation has proved disappointing. B cells in spontaneously undergo increased apoptosis ex vivo (7) .
The EBV-transformed B cell lines from our CVI pathis system usually do not expand nearly as extensively as originally reported and generally do not grow beyond tients also underwent accelerated apoptosis in vitro, accounting for the lower percentage of cell viability of 3 months (unpublished data) unless EBV transformed.
EBV infects and transforms B cell heterogeneous the CVI-transformed cell lines. B cell lines derived from CVI patients also showed increased sensitivity both to populations that express CD21 at multiple stages of differentiation and transformed B cell lines have been CD95 mAb and ionizing radiation-induced apoptosis.
The fact that CD95 mAb and ionizing radiation treata valuable tool in studies of many aspects of B cell function (26) . The majority of circulating CVI B cells ment represent two distinct apoptosis pathways suggests that increased apoptosis by CVI B cells is a genexpress this surface molecule (6); therefore we chose to employ EBV transformation to derive B lymphoblas-eral phenomenon of the CVI B cells studied. An increased susceptibility of CVI B cells to apoptosis toid cell lines as it appeared to be feasible to derive transformed cells reflecting the abnormal B cells pres-certainly may figure in these patients' humoral immunodeficiency. ent in the peripheral blood of CVI patients. Critical in this approach was an understanding of both the subset CD95 (Apo-1/Fas) is a transmembrane molecule and member of the tumor necrosis factor receptor superof CVI subjects and the nature of their B cells in vivo Although several publications attempt to use EBV-family. Ligation of CD95 by anti-CD95 mAb can induce apoptosis of CD95-sensitive cells (30, 31). Abnormal transformed cell lines to study Ig rearrangement and Ig production, they suffer from a small database be-CD95 and CD95 ligand expression can cause autoimmune disease in mice (32, 33) . In humans, CD95 is excause only a few B cell lines were established and studied (13, 14) .
pressed on a restricted subpopulation of fresh peripheral lymphocytes (34-36). The major subpopulation of We established greater than 50 B cell lines from six CVI patients. These B cell lines from the CVI patients, follicular center B lymphocytes which undergo extensive proliferation and apoptosis express CD95 while compared to B cell lines simultaneously derived from normals, usually exhibited a less immature phenotype mantle zone B lymphocytes are CD95-negative. CD95
is expressed preferentially on an sIgD 0 population in characterized by increased levels of sIgM and decreased levels of sIgD and sIgG, was defective in IgG fresh peripheral blood B cells; sIgD / B cells express little CD95. Human B cells increase their expression and IgA production, and more readily underwent apoptosis. Derivation of cell lines that are more sIgM of CD95 after activation and later acquire sensitivity to anti-CD95 mAb-mediated apoptosis (37). CD95-me-demonstrates that the alterations in the CVI cells were not simply a reflection of the immaturity or activation diated apoptosis in antigen-activated B cells may contribute to the regulation of humoral immune response. state of the cells employed to derive the lines.
Patients with CVI present various functional and Heterogeneous expression of CD95 also has been detected on various malignant lymphocytes including B clinical abnormalities. We continue to define these patients and their B cells in a number of ways so as to cell leukemias and lymphomas (20, 34, 39) . EBV-transformed B lymphoblastoid cells express high levels of focus on as homogeneous a disease process as possible.
Yet even within a single CVI subject whose B cells are CD95 and are sensitive to anti-CD95 antibody-induced apoptosis (18) (19) (20) . In this study, we found that the abnormal, there is heterogeneity in regard to the degree of maturation the B cells achieve, with patients level of CD95 expression on CVI B cell lines was 50% brighter than on normal cell lines. This increased CD95 having differing amounts of normal and abnormal B cells. Therefore it is critical for the future study of CVI expression correlated with apoptosis as the CVI B cell lines exhibited increased sensitivity to the effects of to capture B cells representative of the abnormal B cell populations in the patient(s). Our EBV-transformed anti-CD95 mAb. This result is similar to that obtained with fresh CVI B cells which express increased levels cell lines possess many of the important phenotypic and functional characteristics of fresh CVI B cells from of CD95 and are more susceptible to apoptosis.
Just as with the fresh CVI B cells, the patients' EBV-a specific subpopulation of patients, suggesting that we have derived cells representative of the abnormal B derived cell lines had decreased CD38 displays with the CVI B cell lines being 62% positive vs 91% for the cells present in these subjects. The studies presented lay the foundation for using well-defined EBV-transnormal cell lines. CD38 has been proposed to be a novel signal transducing molecule that acts independently of formed cells for studies of CVI B cell gene expression, signal transduction, apoptosis, and Ig production to enthe IP3 pathway (40) (41) (42) . In human B cells, CD38 was found to be associated with the B cell antigen receptor hance our understanding of the nature of the specific differentiation failure observed in these patients. and CD21/CD19 complex (43) and it may serve to inhibit apoptosis (44). Signal generation by the B cell antigen receptor or other surface molecules may be ACKNOWLEDGMENTS partly transduced through CD38. Decreased CD38 ex- (47) . RA also has with which to pursue these studies. been shown to inhibit activation-induced apoptosis in murine T cells, suggesting that the signal triggered
